United Kingdom · Question · Written question
UIN 105469
Blood Cancer: Medical Treatments
Introduced
13 January 2026
Last action
—
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
20 January 2026
Summary
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure NHS patients with Mantle Cell Lymphoma will continue to be able to receive the CAR-T treatment Tecartus after it has exited the Cancer Drugs Fund.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.